Alberto Casellas - Feb 18, 2025 Form 4 Insider Report for Synchrony Financial (SYF)

Role
EVP, CEO--Health & Wellness
Signature
/s/ Danielle Do as attorney in fact
Stock symbol
SYF
Transactions as of
Feb 18, 2025
Transactions value $
$14,494
Form type
4
Date filed
2/20/2025, 06:57 PM
Previous filing
Jan 23, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYF Dividend Equivalent Unit Award $14.5K +222 +0.24% $65.29 93.5K Feb 18, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYF Phantom Stock Units Award $0 +0.693 +0.38% $0.00 182 Feb 18, 2025 Common Stock 0.693 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents dividend equivalent units accrued on February 18, 2025 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
F2 The reported phantom stock units were acquired pursuant to a dividend reinvestment feature under the Synchrony Financial Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled, in cash, six months following the Reporting Person's separation from service to the Company, subject to the requirements set forth in the Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Synchrony Financial common stock.

Remarks:

EVP, CEO--Health & Wellness